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Purpose: Melatonin receptors are seven-pass G protein-coupled receptors located in many tissues throughout the body,
including the corneal epithelium (CE), and relay circadian signals to the target cells. The purpose of this study was to
determine more precisely the cellular distribution of the melatonin receptors in the surface cells of the CE of Xenopus
laevis, and to examine the relative distribution of melatonin receptor subtype expression at different times during the
circadian cycle.
Methods: Cryostat sections and whole corneas of adult Xenopus laevis were processed for immunocytochemistry using
antibodies specific for each of the three melatonin receptor subtypes (Mel1a, Mel1b, and Mel1c). For the circadian studies,
corneas were obtained from euthanized frogs at 4-h intervals during a 24-h period under a 12 h:12 h light-dark cycle.
Double-label immunocytochemistry was performed using a Mel1a antibody in combination with antibodies against Mel1b,
Mel1c, or the zonula occludens protein ZO-1. Corneal whole-mount specimens and corneal sections were analyzed by
laser-scanning confocal microscopy.
Results: All three melatonin receptor subtypes were expressed on the surface and sub-superficial layer of CE cells, but
with different sub-cellular distributions. The Mel1a receptor was highly localized to the lateral plasma membrane of the
surface CE, but also displayed cytoplasmic localization at some times of day, especially at night. Mel1c showed a similar
pattern of labeling to Mel1a, but there were some distinctive differences, insofar as the Mel1c receptors were usually
located immediately basal to the Mel1a receptors. The relative degree of membrane and cytoplasmic labeling of the Mel1c
receptor also oscillated during the 24-h period, but was out of phase with the changes that occurred in the Mel1a receptor
localization. Furthermore, in the late afternoon time point, the Mel1a and Mel1c receptors were highly co-localized,
suggestive of heterodimerization, whereas at other time points, the two receptors were distinctly not co-localized. Double-
label immunocytochemistry of Mel1a and ZO-1 demonstrated that the Mel1a receptor was located basal to the tight
junctions, on the lateral membrane in very close proximity to the ZO-1 protein.
Conclusions:  Mel1a,  Mel1b,  and  Mel1c  receptor  subtypes  are  expressed  in  the  lateral  plasma  membrane  of  the
Xenopus surface CE, at a position in close proximity to the tight junctions that form the corneal diffusion barrier. The very
close association of the Mel1a receptors to the ZO-1 peripheral membrane tight junction proteins is suggestive of a potential
role for melatonin in influencing the rate of tight junction formation or breakdown. The transient co-localization of Mel1a
and Mel1c late in the light period is suggestive of formation of heterodimers that may influence receptor responsiveness
and/or activity during specific periods of the day. The dynamic daily changes in melatonin receptor subtype expression
and localization in the surface CE supports the concept that melatonin signaling may affect circadian activities of the
surface epithelium of the cornea.
Melatonin  receptors  are  located  throughout  the  body,
including many ocular tissues, presumably to mediate the
effects  of  nighttime  melatonin  on  circadian  activities  [1].
Melatonin is a circadian signaling molecule produced at night
time by the pineal gland, retinal photoreceptors, and ciliary
epithelium [2-6]. Melatonin receptors are G protein-coupled
seven-pass transmembrane receptors, and are expressed in the
corneal  epithelium  (CE)  [7-9],  but  their  functions  are
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unknown,  and  the  precise  location  of  the  three  receptor
subtypes on the CE is not known. The turnover of surface CE
cells is thought to occur on a daily basis, but the mechanism
of how this occurs is poorly understood [10,11]. Furthermore,
the CE cells that are directly underneath the surface may
require  a  circadian  signal  to  pre-accumulate  the  proteins
needed to quickly re-establish the CE permeability barrier
after the surface cells are shed [12,13].
The balance in the rate of corneal epithelium proliferation
and desquamation is crucial for maintenance of corneal health
and function, and these processes appear to undergo changes
on  a  daily  basis  [10,11,14-19].  Temporal  coordination  of
desquamation  of  the  surface  epithelium  and  subsequent
formation of the new tight junction barrier by the underlying
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2384cells may perhaps be facilitated by circadian signals such as
melatonin.  To  investigate  the  possibility  that  melatonin
signaling may have a role in the circadian activities of corneal
epithelial cells, the cellular distribution of Mel1a, Mel1b, and
Mel1c melatonin receptor subtype proteins in the Xenopus
laevis CE was examined by confocal immunocytochemistry.
METHODS
Animals  and  tissue  processing  procedures:  Post-
metamorphic Xenopus laevis (African clawed frogs) were
obtained from Xenopus 1 (Dexter, MI) and maintained in
aquaria at 20 °C on a daily 12 h:12 h light–dark schedule
(lights  on:  6:00  AM;  lights  off:  6:00  PM).  Frogs  were
anesthetized  by  immersion  in  tricaine  methanesulfonate
(MS-222) and killed by decapitation. Tissues were fixed for
18 hr at 4 °C in 4% paraformaldehyde in 0.1 M phosphate
buffer, pH 7.4. Corneas were dissected from the eyes and
rinsed with 0.1 M phosphate-buffered saline (PBS), pH 7.4.
For immunocytochemistry of cryostat sections, corneas were
transferred to 30% sucrose in phosphate buffer for 16–20 h at
4  °C,  and  then  mounted  in  Tissue-Tek  O.C.T.  mounting
matrix  (Sakura  Finetek,  Torrance,  CA).  Sagittal  10  μm
sections were cut on a cryostat microtome and collected on
glass slides. For whole mount immunocytochemistry, corneas
were  placed  separately  into  2.0  ml  microfuge  tubes  and
processed for immunocytochemistry. The animals were cared
for in accordance with the guidelines of the Public Health
Service  Policy  on  Humane  Care  and  Use  of  Laboratory
Animals.
ConfocalLmmunocytochemistrySrocedures: )RrLPPXQR
cytochemical localization of melatonin receptors in
Xenopus laevis CE, cryostat sections or whole corneas were
rinsed in PBS, and then incubated in incubation buffer (2%
bovine serum albumin [Sigma, St Louis, MO], 0.2% Triton
X-100, and 0.004% sodium azide in PBS) for 30 min at room
temperature  (RT).  Sections  were  incubated  either  with
chicken  anti-Xenopus  Mel1a  melatonin  receptor  antibody,
which has been previously characterized as specific for the
Xenopus Mel1a receptor subtype [20], rabbit anti-Xenopus
Mel1b  melatonin  receptor  antibody,  which  has  been
previously characterized as specific for the Xenopus Mel1b
receptor  subtype  [21],  or  rabbit  anti-Xenopus  Mel1c
melatonin  receptor  antibody,  which  has  been  previously
characterized  as  specific  for  the  Xenopus  Mel1c  receptor
subtype [22].
The affinity-purified melatonin receptor antibodies were
used at a concentration of 2.3 µg/ml in incubation buffer, and
were incubated with the sections or whole corneas for 3 days
at 4 °C. For negative controls, tissue sections were incubated
in incubation buffer lacking the primary antibody. Following
incubation  with  the  primary  antibody,  sections  or  whole
corneas were rinsed in PBS, and incubated in 5 μg/ml of goat
anti-chicken antibody or goat anti-rabbit antibody conjugated
to AlexaFluor 488 (green; Molecular Probes, Eugene, OR) for
1 h at RT. Sections were rinsed in PBS, then incubated with
0.0005% 4´, 6-diamidino-2-phenylindole (DAPI: Invitrogen,
Carlsbad, CA) nuclear stain for 10 s at RT, followed by a final
rinse  in  PBS.  Corneal  whole  mounts  were  incubated  in
0.0005% DAPI for 10 min at RT, followed by a rinse in PBS.
Corneas were mounted onto glass slides by making 4–5 slits
from  peripheral  to  central  cornea  with  scissors  and  then
compressing the tissue under the coverslips after the mounting
matrix  was  applied  to  achieve  a  flat-mounted  cornea.
Coverslips were mounted onto the slides with Prolong Gold
antifade reagent containing DAPI (Invitrogen).
For  double-label  immunocytochemistry,  the  same
procedure was followed as described for the primary antibody
incubations, except that the first primary antibody was the
Mel1a melatonin receptor antibody, which was subsequently
labeled  with  5  μg/ml  of  goat  anti-chicken  antibody  as  a
secondary antibody, conjugated with AlexaFluor 568 (red;
Molecular Probes). Following the rinse in PBS after the 1-h
secondary antibody incubation, the sections or whole corneas
were incubated in either rabbit anti-Xenopus Mel1b or rabbit
anti-Xenopus Mel1c melatonin receptor antibodies (2.3 µg/
ml)  or  mouse  anti-human  ZO-1  antiserum  (Zymed,  San
Francisco,  CA)  at  a  dilution  of  1:25  for  3  days  at  4  °C.
Following  incubation  with  the  second  primary  antibody,
sections or whole corneas were rinsed in PBS, and incubated
in 5 μg/ml of goat anti-rabbit antibody or goat anti-mouse
antibody conjugated to AlexaFluor 488 (green) (Molecular
Probes) for 1 h at RT. Sections were rinsed in PBS, then
incubated with 0.0005% DAPI nuclear stain for 10 s at RT,
followed  by  a  final  rinse  in  PBS.  Whole  corneas  were
incubated in 0.0005% DAPI for 10 min at RT, followed by a
rinse in PBS. Coverslips were mounted onto the slides with
Prolong  Gold  antifade  reagent  containing  DAPI.  The
immunolabeled  sections  and  corneal  whole  mounts  were
viewed by confocal microscopy, using an Olympus FluoView
1000 laser-scanning confocal microscope (Olympus, Center
Valley,  PA).  The  pinhole  (confocal  aperture  diameter)
conditions were fixed at 105 µm in all images generated in
this  study.  The  objective  lens  used  in  this  study  was  an
Olympus PlanApo N 60x/1.42 Oil lens (∞/0.17/FN26.5). The
control  specimens  were  always  examined  under  identical
conditions to the appropriate non-control specimens.
RESULTS
Melatonin receptor localization in corneal cryostat sections:
Mel1a  receptor  immunoreactivity  in  Xenopus  CE  was
observed to be localized to the surface layer of cells in sagittal
sections (Figure 1A). In whole mount corneas, the Mel1a
immunoreactivity of the surface CE was most intense in the
plasma  membranes  (Figure  1E).  Mel1b  receptor
immunoreactivity was also localized to the surface layer of
cells in sagittal sections (Figure 1B). In whole mount corneas,
although there was immunoreactivity present in the lateral
plasma membranes, there was also a considerable amount of
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2385immunoreactivity in small cytoplasmic compartments (Figure
1F).  Similarly,  Mel1c  receptor  immunoreactivity  was
localized  mostly  to  the  surface  layer  of  cells  in  sagittal
sections, although some punctate immunolabeling was also
observed in the more basal layers of the CE (Figure 1C). In
whole mount corneas, the Mel1c immunoreactivity of the
surface CE was most intense in the lateral plasma membranes,
but  there  was  also  some  immunolabeling  of  cytoplasmic
compartments  (Figure  1G).  Sections  and  whole  corneas
treated  without  primary  antibody  were  devoid  of  specific
immunoreactivity (Figures D, H). These observations suggest
that there is a differential expression of the three melatonin
receptor subtypes in the Xenopus CE.
Double-labeled  cryostat  sections  of  Xenopus  CE
demonstrated  both  a  co-localization  and  differential
distribution of Mel1a, Mel1b, and Mel1c melatonin receptor
immunoreactivity at the mid-light (12N) and mid-dark (12M)
time points (Figure 2). Since the Mel1a antibody was raised
in chickens, and the Mel1b and Mel1c antibodies were raised
in  rabbits,  the  only  combinations  of  receptor
immunocytochemical double labeling that were feasible were
the  combinations  of  Mel1a  with  Mel1b,  and  Mel1a  with
Mel1c. At the mid-light time point (12N), the red Mel1a
immunolabeling was observed in the plasma membrane, and
the green immunoreactivity of the Mel1b label was observed
in the cytoplasm (Figure 2A). The region of the cells that are
labeled yellow indicates co-localization of the Mel1a and
Mel1b, insofar as both receptors appeared to be located on the
plasma membrane (Figure 2A). At the mid-dark (12M) time
point, the pattern of both Mel1a and Mel1b immunoreactivity
appeared very similar to the 12N time point in these cryostat
sections (Figure 2B).
At  the  mid-light  time  point  (12N),  the  red  Mel1a
immunolabeling was again observed in the plasma membrane
and cytoplasm, and the green immunoreactivity of the Mel1c
label was observed not only in the cytoplasm of the surface
layer of CE, but also in the sub-superficial layer of cells
(Figure 2C). Again, the region of the cells that were labeled
yellow indicates a close proximity or co-localization of the
Mel1a and Mel1c labels. At the mid-dark (12M) time point,
Mel1a (red) was present in the surface layer of cells, but Mel1c
immunoreactivity (green) appeared to be greatly reduced in
these cells and in the sub-superficial cells, insofar as there
appeared  to  be  only  a  small  amount  of  yellow  punctate
immunoreactivity  in  the  surface  cell  cytoplasm  in  these
cryostat sections (Figure 2D). These observations suggest that
there is a translocation and/or change in expression of some
of the melatonin receptor subtypes between the light and dark
period, and/or turnover of surface CE cells.
Mel1a and Mel1c receptor localization in whole corneas: A
more detailed analysis of corneal whole mounts that were
double-labeled  with  Mel1a  and  Mel1c  antibodies  was
Figure 1. Mel1a, Mel1b, and Mel1c immunocytochemistry of cryostat sections and whole mounts of Xenopus laevis corneal epithelium. A-
C: Cryostat sections of corneas obtained during the light period were immunolabeled with Mel1a, Mel1b, or Mel1c receptor antibodies. Arrows
in panel A indicate the immunolabeled plasma membranes of the surface epithelium. D: The control specimen was processed in the absence
of primary antibody. E-G: Whole mount preparations of corneas obtained during the light period were immunolabeled with Mel1a, Mel1b,
or Mel1c receptor antibodies. H: The control whole mount specimen was processed in the absence of primary antibody. Primary antibodies
were labeled with secondary antibody conjugated to AlexaFluor 488 (green fluorescence). Most of the Mel1a receptor labeling (A and E)
occurs in the lateral plasma membrane of the surface epithelium, whereas there is a higher proportion of Mel1b (B and F) and Mel1c (C and
G) labeling also present in cytoplasmic compartments in addition to the lateral membranes. Note that no specific immunolabeling is detected
in the control specimens (D and H). Nuclei are stained with DAPI. The magnification bar (H) represents 20 µm.
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2386performed  to  determine  the  relative  locations  of  the  two
receptor subtypes in the surface CE cells. In a typical mid-
light (12N) specimen, both Mel1a and Mel1c immunolabeling
was observed on the lateral plasma membrane, with some
immunoreactivity also occurring in the cytoplasm (Figure 3).
The labeling of the plasma membrane was characterized by a
pattern of distinct areas of Mel1a (red), Mel1c (green), and
both receptors (yellow; Figure 3A).
Three-dimensional reconstructions of confocal z-stacks
of optical slices were rotated at 72° on the x-axis to enable
optimal viewing of the pattern of immunolabeling. The rotated
image demonstrated that the red Mel1a labeling was generally
located apically to the green Mel1c labeling (Figure 3B). The
pattern of Mel1a labeling was characterized by a relatively
broad  continuous  band  of  red  label  on  the  lateral  plasma
membrane  of  the  majority  of  surface  CE  cells.  In  many
instances, a somewhat broader band of green Mel1c labeling
appeared directly basal to the Mel1a label, although there were
some areas in which the green Mel1c labeling was lacking or
diminished. Some yellow labeling was observed, indicating
the very close proximity of the red Mel1a and green Mel1c
immunolabeling. Furthermore, there were many areas in the
red  Mel1a  band  in  which  some  yellow  labeling  was
interspersed between areas of red Mel1a labeling, suggesting
that some green Mel1c-labeled receptors were present in the
area of the lateral membrane that contained mostly Mel1a-
labeled receptors.
For  further  confirmation  that  the  Mel1a  labeling  was
located  apically  to  the  Mel1c  immunolabeling,  individual
400-nm optical slices were analyzed for their relative amounts
of Mel1a and Mel1c immunolabeling (Figure 4). In the most
apical slice (slice 0.0 µm), red Mel1a labeling was observed
prominently  (Figure  4A),  but  almost  no  green  or  yellow
labeling was displayed. Progressing basally through the 400-
nm  optical  slices,  yellow  immunolabeling  became  more
prominent (Figure 4B-D) with concomitant decreases in red
Mel1a  labeling.  The  green  Mel1c  labeling  then  became
increasingly prominent (Figure 4D-F), so that by optical slice
2.0 µm (Figure 4F), almost all plasma membrane labeling was
due exclusively to the green Mel1c label. Most of the punctate
green Mel1c label that was observed interior to the plasma
membranes (Figure 4F) appeared to be due to Mel1c labeling
of the lateral membrane as it flared obliquely between adjacent
cells. So, some labeling that may initially appear as perhaps
being cytoplasmic labeling is actually labeling of the lateral
membranes that are oriented at an oblique angle.
Mel1a and Mel1b receptor localization in whole corneas: An
analysis of corneal whole mounts that were double-labeled
with Mel1a and Mel1b antibodies was performed in a manner
identical to those performed on the Mel1a-Mel1c double-
labeled specimens. In a typical mid-light (12N) specimen,
both Mel1a and Mel1b immunolabeling was observed on the
lateral plasma membranes, but with a significant amount of
Mel1b  immunoreactivity  also  occurring  in  the  cytoplasm
(Figure 5A). However, the pattern of Mel1a-Mel1b labeling
was significantly different from what was observed for the
Mel1a-Mel1c labeling pattern.
Figure 2. Mel1a, Mel1b, and Mel1c double-label immunocytochemistry of cryostat sections of Xenopus laevis corneal epithelium. A and C:
Corneas obtained at 12:00 noon (12N) in the light. B and D: Corneas obtained at 12:00 midnight (12M) in the dark. Sections were
immunolabeled with Mel1a and either Mel1b or Mel1c receptor antibodies. Mel1a labeling is represented in red, and Mel1b and Mel1c labeling
is represented in green. Yellow indicates regions of co-localization of the red and green signal. Melatonin receptors are expressed in the surface
epithelium, but their relative levels of expression and distribution change between 12N and 12M. Arrows indicate the immunolabeled plasma
membranes of the surface epithelium. Nuclei are stained with DAPI. The magnification bar (D) represents 20 µm.
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2387The  Mel1a-Mel1c  immunolabeling  (Figure  3)  was
characterized by a relatively broad continuous band of Mel1a
on the lateral membrane of the majority of surface cells, with
a  somewhat  broader,  less  defined  band  of  green  Mel1c
labeling directly basal to the Mel1a label. In contrast, the
Mel1a-Mel1b labeled cells were characterized by a broad
band of merged yellow labeling, interdigitating with a lesser
amount of red Mel1a labeling (Figure 5B). This pattern of
labeling  suggests  that  a  majority  of  Mel1a  and  Mel1b
receptors are located in very close proximity to each other on
the lateral membrane, with a lesser amount of Mel1a that is
not juxtaposed to the Mel1b receptor. Essentially all the green
Mel1b labeling (that did not contribute to the merged yellow
lateral  membrane  labeling)  was  present  in  cytoplasmic
compartments, with most or all of the Mel1b labeling of the
lateral membranes merged with the red Mel1a label to create
the  merged  yellow  labeling  of  the  membrane.  Therefore,
whereas the Mel1c labeling was located basally to the Mel1a
label (Figure 3B), the Mel1b label had the same cellular apical/
basal position as the Mel1a label (Figure 5B).
Figure  3.  Confocal  double-label
immunocytochemical  localization  of
Mel1a and Mel1c in Xenopus corneal
whole mounts. A: The specimen shown
was  obtained  in  the  mid-light  period
(12N).  Both  Mel1a  and  Mel1c
immunolabeling  is  observed  on  the
lateral  plasma  membrane,  with  some
immunoreactivity also occurring in the
cytoplasm. The labeling of the plasma
membrane  displays  distinct  areas  of
Mel1a (red), Mel1c (green), and both
receptors (yellow). Arrows are provided
as reference points to indicate the same
points on B. The inset illustrates the 72°
rotation on the x-axis of the image in
A, indicating the orientation relative to
the  viewer’s  eye  in  B.  B:  Three-
dimensional reconstructions of confocal
z-stacks of optical slices were rotated at
72°  degrees  on  the  x-axis  to  enable
optimal  viewing  of  the  pattern  of
immunolabeling.  The  rotated  image
shows  that  the  red  Mel1a  labeling  is
generally located apically to the green
Mel1c labeling. The Mel1a labeling is
seen  as  a  relatively  broad  continuous
band of red label on the lateral plasma
membrane of the majority of surface CE
cells.  A  somewhat  broader  band  of
green Mel1c labeling appears directly
basal to the Mel1a label. Some yellow
labeling  is  occasionally  observed,
indicating  some  co-localization  of
Mel1a and Mel1c. There are many areas
in the red Mel1a band in which yellow
labeling is interspersed between areas of
red  Mel1a  labeling,  suggesting  that
some green Mel1c-labeled receptor is
interdigitated among the Mel1a-labeled
receptor. The confocal images in both
panels are comprised of 13 optical slices
of  400  nm  each  in  the  z-series.  The
magnification bar (B) represents 20 µm.
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2388To further confirm that the Mel1a and Mel1b receptors
were located at the same apical/basal position, individual 400-
nm optical slices were analyzed for their relative amounts of
Mel1a and Mel1b immunolabeling (Figure 6), as was done for
the Mel1a-Mel1c labeling in Figure 4. In all slices, there was
not  a  transition  from  red  to  green  labeling,  but  instead  a
predominance of yellow labeling with some interspersed red
labeling (Figure 6). This is in contrast to the Mel1a-Mel1c
pattern of labeling, in which there was a distinctive transition
from red Mel1a to green Mel1c labeling (Figure 4). This
analysis confirmed that the Mel1a and Mel1b receptors have
a spatial relationship distinct from that of the Mel1a and Mel1c
receptors.
Mel1a receptor and ZO-1 localization in whole corneas: An
analysis of corneal whole mounts that were double-labeled
with Mel1a and ZO-1 antibodies was performed in a manner
identical to those performed on the Mel1a-Mel1c double-
labeled specimens. ZO-1 is a cytoplasmic protein that binds
directly to integral membrane proteins of zonula occludens,
and is therefore a marker for tight junctions. Double-label
immunocytochemistry with antibodies to Mel1a and to ZO-1
were  performed  to  determine  the  relative  location  of  the
melatonin  receptors  to  tight  junctions  on  the  lateral
membranes of CE cells.
In a typical light-adapted (4PM) specimen, both Mel1a
and ZO-1 immunolabeling was observed on the lateral plasma
membrane, with some immunoreactivity also occurring in the
cytoplasm  (Figure  7).  This  is  representative  of  what  was
observed at several other time points (data not shown). The
Mel1a (red) labeling was present predominantly as very broad
bands on the lateral membranes as described earlier, with a
further  observation  that  red  Mel1a  punctate  labeling  was
abundant on obliquely-oriented lateral membranes (Figure
7A) as described earlier for Mel1a and Mel1c receptors. The
plasma  membrane  was  characterized  by  an  abundance  of
yellow labeling, indicative of a very close proximity of Mel1a
(red) and ZO-1 (green). The ZO-1 pattern of labeling was
much more discreet than the Mel1a pattern, insofar as it was
not as broadly distributed on the lateral membrane. Most of
the plasma membrane labeling demonstrated the presence of
Figure 4. Localization of Mel1a and Mel1c in progressive confocal optical slices of Xenopus corneal epithelium. A: Image of the most
superficial surface of the surface corneal epithelium. Note that only the red Mel1a immunoreactivity is present on the lateral membranes. B-
F: As the 0.4 µm slices progress deeper into the corneal epithelium layer, the Mel1a immunoreactivity lessens, whereas the green Mel1c
immunoreactivity increases (note arrowheads indicating an example of this), indicating that the Mel1c receptor is located basal to the Mel1a
receptor. Nuclei are stained with DAPI. The magnification bar (F) represents 20 µm.
Molecular Vision 2009; 15:2384-2403 <http://www.molvis.org/molvis/v15/a255> © 2009 Molecular Vision
2389both ZO-1 and Mel1a, but there were some areas in which
only ZO-1 or only Mel1a were present. For example, cells that
have very little apical surface membrane are assumed to be
cells that have very recently reached the apical surface, and
may  not  have  yet  formed  fully-functional  tight  junction
barriers;  in  many  instances,  these  cells  with  small  apical
profiles expressed ZO-1 (green) labeling but a paucity of
Mel1a (red) labeling (Figure 7A).
As  described  above  for  the  analysis  of  Mel1a-Mel1c
double-label experiments, three-dimensional reconstructions
of confocal z-stacks of optical slices were rotated at 72° on
the  x-axis  to  enable  optimal  viewing  of  the  pattern  of
immunolabeling. The rotated image demonstrated that the
green ZO-1 labeling was generally located apically to the red
Mel1a labeling (Figure 7B). The pattern of ZO-1 labeling was
characterized by a relatively narrow continuous band of green
label  on  the  lateral  plasma  membrane  of  the  majority  of
surface CE cells. A much broader band of red Mel1a labeling
appeared directly basal to the ZO-1 label, although there were
some areas in which the red Mel1a labeling was lacking or
Figure  5.  Confocal  double-label
immunocytochemical  localization  of
Mel1a and Mel1b in Xenopus corneal
whole mounts. A: The specimen shown
was  obtained  in  the  mid-light  period
(12N).  Both  Mel1a  (red)  and  Mel1b
(green) immunolabeling is present on
the lateral plasma membrane appearing
mostly  as  the  merged  yellow
fluorescence  indicative  of  co-
localization.  A  significant  amount  of
green Mel1b immunoreactivity is also
present  in  the  cytoplasm.  Arrows  are
provided as reference points to indicate
the same points on panel B. The inset
illustrates the 72° rotation on the x-axis
of  the  image  in  A,  indicating  the
orientation relative to the viewer’s eye
in  B.  B    :  Three-dimensional  recon-
structions  of   confocal   z-stacks   of
optical slices were rotated at 72° degrees
on the x-axis to enable optimal viewing
of the pattern of immunolabeling. The
rotated  image  shows  that  the  Mel1a-
Mel1b-labeled  cells  are  characterized
by  a  broad  band  of  merged  yellow
labeling,  interdigitating  with  a  lesser
amount  of  red  Mel1a  labeling.  This
pattern  of  labeling  suggests  that  a
majority of Mel1a and Mel1b receptors
are located in very close proximity to
each other on the lateral membrane. The
confocal  images  in  both  panels  are
comprised of 19 optical slices of 400 nm
each in the z-series. The magnification
bar (B) represents 20 µm.
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2390diminished.  Significant  yellow  labeling  was  observed,
indicating that the Mel1a receptor is in very close proximity
to ZO-1. These observations indicate that Mel1a receptors are
located on the lateral membranes basal to tight junctions in
Xenopus surface CE cells.
Analysis of individual 400-nm optical slices confirmed
that the ZO-1 labeling was located apically to the Mel1a
immunolabeling (Figure 8). In the most apical slice (slice 0.0
µm), red Mel1a, green ZO-1, and merged yellow labeling was
observed  (Figure  8A).  This  is  in  contrast  to  the  almost
exclusive localization of Mel1a labeling in the most apical
optical slice described for the Mel1a-Mel1c double-labeling
(Figure 3A). Progressing basally through the 400-nm optical
slices,  the  red  Mel1a,  green  ZO-1,  and  merged  yellow
persisted on the lateral membranes, with a general increase in
the expression of the red Mel1a label (Figure 8B-D). Red
Mel1c labeling continued to become increasingly prominent
in the more basal slices (Figure 8D-F), so that by optical slice
2.0  µm  (Figure  8F),  essentially  all  the  plasma  membrane
labeling was due to the red Mel1a label. Most of the punctate
red  Mel1a  label  that  was  observed  interior  to  the  plasma
membranes  (Figure  8B-F)  appeared  to  be  due  to  Mel1a
labeling of the lateral membrane as it flared obliquely between
adjacent cells. Some ZO-1 immunolabeling was observed in
cytoplasm not associated with the plasma membrane, which
is anticipated, since ZO-1 is known to have a cytoplasmic
localization [23,24].
Diurnal rhythm of melatonin receptor localization: Mel1a-
Mel1c double-label immunocytochemistry was performed on
whole corneas obtained from seven frogs at 4-h intervals
during a 24-h period. The purpose was to determine if there
were any observable changes in the expression or distribution
of melatonin receptors in the surface CE that might potentially
reflect diurnal or circadian changes in cellular responsiveness
to melatonin. Frogs were housed under a 12 h:12 h light–dark
cycle (6:00 AM: lights on; 6:00 PM: lights off).
At 8:00 AM (2 h after lights on), Mel1c (green) labeling
was  localized  to  the  lateral  plasma  membrane  of  a
Figure 6. Localization of Mel1a and Mel1b in progressive confocal optical slices of Xenopus corneal epithelium. A: Image of the most
superficial surface of the surface corneal epithelium. Note the predominance of yellow (merged red and green) labeling of most lateral
membranes, with a lesser amount of interdigitated red Mel1a labeling (note arrowheads indicating an example of this). B-F: As the 0.4-µm
slices progress deeper into the corneal epithelium layer , there is not a transition from red to green labeling as was seen with Mel1a-Mel1c,
but instead the predominance of yellow labeling with some interspersed red labeling is maintained throughout all slices. Nuclei are stained
with DAPI. The magnification bar (F) represents 20 µm.
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2391subpopulation of CE cells (Figure 9A). Mel1a (red) labeling
was  also  observed  on  the  lateral  membranes  of  a
subpopulation  of  CE  cells  (Figure  9B).  Of  these  two
subpopulations of cells, some cells expressed only Mel1a or
only Mel1c, whereas other cells expressed both Mel1a and
Mel1c  (Figure  9C).  Furthermore,  in  most  instances,  the
receptor immunolabeling was not uniform throughout the cell.
A common pattern of receptor distribution was a dominance
of one receptor subtype on a portion of the lateral membrane,
and a dominance of the other receptor subtype on a different
portion of the membrane.
At 12:00 N (noon; middle of the light period), Mel1c
(green) immunolabeling was present in the lateral membranes
of a subpopulation of CE cells, and Mel1a labeling (red) in
another subpopulation of cells (Figure 9D-F). In contrast to
the pattern observed at 8:00 AM, there was not nearly as much
co-localization as had been observed at the earlier time point
(Figure 9F). The two populations of cells appeared to be more
distinct, and many of the Mel1c-immunoreactive cells were
Figure  7.  Confocal  double-label
immunocytochemical  localization  of
Mel1a  and  ZO-1  in  Xenopus  corneal
whole  mounts.  A:  Mel1a  and  ZO-1
immunolabeling  is  observed  on  the
lateral  plasma  membrane,  with  some
immunoreactivity also occurring in the
cytoplasm.  Mel1a  (red)  labeling  is
present  predominantly  as  very  broad
bands  on  the  lateral  membranes,
including the obliquely-oriented lateral
membranes  (arrows).  The  plasma
membrane has an abundance of yellow
labeling,  indicative  of  a  very  close
proximity of red Mel1a and green ZO-1.
The ZO-1 labeling was not as broadly
distributed on the lateral membrane. The
inset illustrates the 72° rotation on the x-
axis of the image in A, indicating the
orientation relative to the viewer’s eye
in  B.  B    :   Three-dimensional  recon-
structions   of   confocal   z-stacks    of
optical slices were rotated at 72° degrees
on the x-axis to enable optimal viewing
of  the  pattern  of  immunolabeling.
Arrows are provided as reference points
to indicate the same points on panel A.
The rotated image shows that the green
ZO-1  labeling  is  generally  located
apically to the red Mel1a labeling. The
ZO-1  labeling  appears  as  a  relatively
narrow  continuous  band  of  green
labeling  on  the  lateral  plasma
membrane,  whereas  a  much  broader
band  of  red  Mel1a  labeling  appears
directly  basal  to  the  ZO-1  label.
Significant yellow labeling is observed,
indicating that the Mel1a receptor is in
very  close  proximity  to  ZO-1.  The
confocal  images  in  both  panels  are
comprised of seven optical slices of 400
nm  each  in  the  z-series.  The
magnification bar (B) represents 20 µm.
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2392overlying the red Mel1a cells, and sometimes appeared to be
attached to neighboring Mel1a-immunoreactive cells, thus
showing some co-localization (yellow). There appeared to be
more Mel1a and Mel1c cytoplasmic labeling at 12:00 N than
at 8:00 AM, but the cytoplasmic immunolabeling of the two
receptors was not co-localized.
At 4:00 PM (10 h after lights on), most of the Mel1a and
Mel1c  immunolabeling  was  co-localized  on  the  lateral
membranes, with some cytoplasmic labeling not co-localized
(Figure 9G-I). Also, the fluorescent intensity of both Mel1a
and  Mel1c  immunolabeling  was  much  higher  than  at  the
previous time points, although this is not demonstrated in the
figure panels, because the images would have been over-
saturated if presented at the equivalent intensity settings as in
the previous time points.
At 8:00 PM (2 h after lights off), Mel1c immunolabeling
was almost exclusively located in the cytoplasm (Figure 10A),
whereas there was intense Mel1a immunoreactivity present in
the lateral membranes and also in the cytoplasm (Figure 10C).
The cytoplasmic immunolabeling of Mel1a and Mel1c was
not co-localized (Figure 10C).
At 12:00 M (midnight; middle of the dark period), most
of the Mel1c immunoreactivity remained in the cytoplasm,
although some lateral membrane labeling was also detected
(Figure 10D). Mel1a immunoreactivity was still predominant
in  the  lateral  membranes,  but  there  were  many  irregular-
appearing cytoplasmic compartments that expressed Mel1a
immunoreactivity, and these structures did not co-localize
with  the  Mel1c  cytoplasmic  labeling  (Figure  10F).
Essentially,  all  the  Mel1c  lateral  membrane  labeling  co-
localized with the Mel1a membrane labeling (Figure 10F).
At 4:00 AM (10 h after lights off), most of the Mel1c
immunoreactivity was located in the cytoplasm, with very
little membrane labeling detected (Figure 10G). In contrast,
most of the Mel1a immunoreactivity was located on the lateral
membranes, with some immunoreactivity also appearing in
the irregular cytoplasmic compartments (Figure 10H). The
Figure 8. Localization of ZO-1 and Mel1a in progressive confocal optical slices of Xenopus corneal epithelium. A: Image of the most superficial
surface of the surface corneal epithelium. In the most apical slice (slice 0.0 µm), red Mel1a, green ZO-1, and merged yellow labeling is
observed in variable amounts on different cell membranes. B-F: As the 0.4-µm slices progress deeper into the corneal epithelium layer, the
green ZO-1 immunoreactivity gradually lessens, whereas the red Mel1a immunoreactivity increases (note arrowheads indicating an example
of this), indicating that the Mel1a receptor is located basal to the zonula adherens, but is in very close proximity in most of the slices (A-C).
Nuclei are stained with DAPI. The magnification bar (F) represents 20 µm.
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2393Figure 9. Mel1a and Mel1c immunocytochemistry of whole-mounted Xenopus laevis surface corneal epithelium obtained at 4-h intervals
during a 24-h light–dark cycle. Frogs were housed under a 12 h:12 h light–dark cycle (6:00 AM: lights on; 6:00 PM: lights off). All tissues
in this figure were obtained in the light. Mel1c labeling is represented in green (A, D, and G) and Mel1a labeling is represented in red (B,
E, and H). The yellow labeling in the merged images (C, F, and I) indicates regions of co-localization of the red and green signal. A-C:
Corneas obtained at 8:00 AM (2 h after lights on). Mel1c and Mel1a labeling is localized to the lateral plasma membrane of different yet
overlapping subpopulations of cells. D-F: Corneas obtained at 12:00 N (mid-light). Mel1a and Mel1c immunolabeling is present on the lateral
membranes of different populations of CE cells, with some minor regions of overlap. G-I: Corneas obtained at 4:00 PM (2 h before lights
off). Most of the Mel1a and Mel1c immunolabeling is co-localized on the lateral membranes, with some cytoplasmic labeling that is not co-
localized. Nuclei are stained with DAPI. The confocal images in all panels are comprised of three optical slices of 400 nm each in the z-series.
The magnification bar (I) represents 20 µm.
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2394Figure 10. Mel1a and Mel1c immunocytochemistry of whole-mounted Xenopus laevis surface corneal epithelium obtained at 4-h intervals
during a 24-h light–dark cycle. Frogs were housed under a 12 h:12 h light–dark cycle (6:00 AM: lights on; 6:00 PM: lights off). All tissues
in this figure were obtained in the dark. Mel1c labeling is represented in green (A, D, and G) and Mel1a labeling is represented in red (B, E,
and H). The yellow labeling in the merged images (C, F, and I) indicates regions of co-localization of the red and green signal. A-C: Corneas
obtained at 8:00 PM (2 h after lights off). Mel1c immunolabeling is almost exclusively located in the cytoplasm, but there is intense Mel1a
immunoreactivity present in the lateral membranes, and also in the cytoplasm. The cytoplasmic immunolabeling of Mel1a and Mel1c is not
co-localized. D-F: Corneas obtained at 12:00 M (mid-dark). Most of the Mel1c immunoreactivity is in the cytoplasm, although some lateral
membrane labeling is also detected. Mel1a immunoreactivity is predominant in the lateral membranes, but there are many irregular-appearing
cytoplasmic compartments that express Mel1a immunoreactivity, and they do not co-localize with the Mel1c cytoplasmic labeling. Essentially,
all Mel1c lateral membrane labeling is co-localized with Mel1a membrane labeling. G-I: Corneas obtained at 4:00 AM (2 h before lights on).
Most  of  the  Mel1c  immunoreactivity  is  located  in  the  cytoplasm,  with  very  little  membrane  labeling  detected.  Most  of  the  Mel1a
immunoreactivity is located on the lateral membranes, with some immunoreactivity also appearing in irregular cytoplasmic compartments.
The Mel1a and Mel1c cytoplasmic labeling is not co-localized. Nuclei are stained with DAPI. The confocal images in all panels are comprised
of three optical slices of 400 nm each in the z-series. The magnification bar (I) represents 20 µm.
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2395Mel1a and Mel1c cytoplasmic labeling was not co-localized
(Figure 10I).
A more detailed analysis was performed on the two time
points that demonstrated the greatest differences in receptor
localization. The 8:00 AM time point showed that some areas
of lateral membranes of some cells expressed only Mel1a or
only  Mel1c  labeling,  whereas  other  parts  of  the  lateral
membranes expressed both Mel1a and Mel1c (Figure 9C). In
contrast, at the 4:00 PM time point, almost all Mel1a and
Mel1c lateral membrane immunolabeling was co-localized
(Figure 9I). Three-dimensional reconstructions of confocal z-
stacks of optical slices of the 8:00 AM and 4:00 PM specimens
were rotated at 63° on the x-axis to enable optimal viewing of
the pattern of immunolabeling. At 8:00 AM, areas of the
lateral membranes expressed only the red Mel1a receptor label
or the green Mel1c receptor label (Figure 11). In areas of
membrane that expressed both red Mel1a and green Mel1c
labeling, there appeared to be two different patterns. In some
areas of merged Mel1a-Mel1c co-localization only the yellow
color was observed, indicating such a close proximity of the
red Mel1a and green Mel1c labels that it exceeded the level
of resolution provided by the methods used in this analysis
(Figure 11E). In contrast, there were also areas of membrane
that expressed the yellow co-localization, but appeared to
have  small  areas  of  red  Mel1a  or  green  Mel1c  label
interdigitated with the yellow label (Figure 11E). In contrast
to the 8:00 AM time point, the lateral membranes of the 4:00
PM  time  point  showed  a  much  more  uniform  pattern  of
immunolabeling. In the most apical portion of the membranes,
the yellow co-localization label was predominant. However,
in  the  more  basal  area  of  the  lateral  membranes,  distinct
punctate red Mel1a and green Mel1c labeling was observed
(Figure 11F). This pattern of distinct punctate red Mel1a and
green Mel1c labeling on the more basal portion of the lateral
membrane  was  also  observed  at  the  8:00  AM  time  point
(Figure 10E). This suggests that in the more apical areas of
the lateral membranes, the Mel1a and Mel1c receptors are in
close juxtaposition to each other, whereas in the more basal
areas, the Mel1a and Mel1c receptors are not in very close
proximity to each other.
DISCUSSION
The corneal epithelium (CE) is a stratified squamous non-
keratinized epithelium. The surface layer of the CE is the only
layer of cells that forms tight junctions, which provides the
barrier function of the cornea [25-28]. The basal layer of CE
cells appears to undergo a circadian rhythm in their rate of
proliferation [15-19,29], and as the cells divide, they give rise
to daughter cells that are displaced apically. These epithelial
cells (termed “wing cells”) continue to be displaced apically
as additional cells are generated from the basal epithelium.
The addition of new cells from the basal layer is balanced by
a loss of epithelial cells at the surface. The surface epithelial
cells are desquamated (“shed”) on a daily basis as part of a
renewal process [10,11].
We assume that appropriate temporal coordination of the
assembly and disassembly of junctional complexes on the
surface epithelial cells is necessary for optimal CE function.
The expression of melatonin receptors on the surface cells of
the  CE  suggests  that  melatonin  may  provide  a  signal  to
coordinate some circadian activities of these cells. Melatonin
is  the  major  chemical  output  of  the  circadian  clock,  and
performs a variety of functions in many tissues [1]. Melatonin
is produced by the pineal gland, retinal photoreceptors, and
ciliary epithelium on a circadian rhythm, with highest levels
produced at night [6,30,31]. The source of melatonin that
reaches the CE may therefore be the pineal gland, retina,
ciliary epithelium, or a combination of these organs. The
purpose of this study was to describe the relative distribution
of the melatonin receptor subtypes in Xenopus laevis surface
CE cells, and to examine the potential changes in sub-cellular
receptor distribution with time of day. We report here that the
Mel1a, Mel1b, and Mel1c receptors are located on the lateral
membranes in the surface layer of cells in Xenopus CE, and
that their relative distribution on the lateral membranes and
cytoplasmic compartments oscillates during a 24-h period.
Furthermore, the Mel1a receptor is closely juxtaposed to the
zonula  occludens  protein  ZO-1,  which  may  reflect  a
functional relationship between the receptor and the CE tight
junctions.
Previous  studies  have  demonstrated  that  the  Mel1a,
Mel1b, and Mel1c receptors are present in the CE of Xenopus
laevis  and  the  chick  [7,8,21],  and  the  MT1  receptor  is
expressed in human CE [9]. The MT1, MT2, and orphan G
protein-coupled  receptor  50  (GPCR50)  receptors  are  the
mammalian  orthologs  of  Mel1a,  Mel1b,  and  Mel1c,
respectively [32,33]. We chose to use Xenopus as the animal
model for these studies since it has been a popular animal
model in the study of the role of melatonin and circadian
rhythms in ocular tissues [2,34,35], and the antibodies that we
have produced against the three melatonin receptor subtypes
are specific for the receptor sequences in Xenopus.
In an attempt to further our understanding of the potential
for regional variations in Xenopus surface CE morphology,
we analyzed hematoxylin and eosin (H&E)-stained corneal
paraffin  sections  generated  in  a  previous  publication  on
Xenopus laevis histology [36]. We observed that, contrary to
a commonly held assumption that Xenopus laevis do not have
eyelids, they do indeed have a lower eyelid [36]. Moreover,
the inferior region of the cornea that is potentially covered by
this lower eyelid has a thinner CE than does the superior
cornea that is not covered by the eyelid (data not shown). The
CE of the inferior cornea is about 30% thinner than the CE of
the superior cornea due to about two fewer cell layers near the
corneal surface. This suggests that the gentle abrasion caused
by  eyelid  blinking  facilitates  CE  cell  desquamation,  as  is
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2396commonly assumed. This feature of the Xenopus cornea may
provide a uniquely valuable model insofar as the influence of
eyelid  blinking  on  the  rate  of  CE  desquamation  can  be
accounted  for  in  future  studies  on  the  potential  role  of
melatonin signaling in CE turnover.
Figure 11. Confocal analysis of Mel1a and Mel1c immunocytochemistry of whole-mounted Xenopus laevis surface corneal epithelium at two
separate time points. Three-dimensional reconstructions of confocal z-stacks of optical slices of the 8:00 AM (A, C, and E) and 4:00 PM
(B, D, and F) specimens were rotated at 63° on the x-axis to enable optimal viewing of the pattern of immunolabeling. At 8:00 AM (A, C,
and E), areas of lateral membranes express only the red Mel1a receptor label (large arrow) or the green Mel1c receptor label (large arrowhead).
In some areas of merged Mel1a-Mel1c co-localization, only the yellow color is observed (small arrow), indicating receptor co-localization.
There are also areas of membrane that express the yellow co-localization but have small areas of red Mel1a or green Mel1c label interdigitated
with the yellow label (asterisks). At 4:00 PM (B, D, and F), the lateral membranes show a more uniform pattern of immunolabeling than
observed at the 8:00 AM time point. The yellow co-localization label is predominant in the most apical portion of the membranes, but in the
more basal area of the lateral membranes distinct punctate red Mel1a and green Mel1c labeling is also observed. Nuclei are stained with DAPI.
The confocal images in panels A and E are comprised of 16 optical slices of 400 nm each in the z-series. The confocal images in panels B
and F are comprised of 16 optical slices of 400 nm each in the z-series. The images in panels C and D are comprised of a single optical slice
of 400 nm. The magnification bar (F) represents 20 µm.
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2397Relative distribution of Mel1a and Mel1c in the corneal
surface epithelium: The relative locations of the Mel1a and
Mel1c  receptor  subtype  immunoreactivity  in  the  corneal
surface epithelium were examined in preparations of whole
cornea obtained during the mid-light period (12:00 N; Figure
3).  Most  of  the  Mel1a  (red)  and  Mel1c  (green)
immunoreactivity  is  localized  to  the  lateral  plasma
membranes,  with  some  punctate  immunolabeling  also
occurring in the cytoplasm. The Mel1a and Mel1c punctate
labeling  that  occurs  in  the  cytoplasm  is  not  co-localized,
suggesting  that  the  two  receptors  are  located  in  separate
cytoplasmic  compartments.  When  stacks  of  the  confocal
optical slices are viewed at an angle of 72°, it becomes obvious
that the Mel1a receptors are located directly apically to the
Mel1c receptors (Figure 3B). This is an unanticipated and
interesting  observation,  and  suggests  that  there  may  be  a
mechanism by which the two receptor subtypes are tethered
to maintain a precise proximity to each other. However, the
relative lack of merged yellow fluorescence does not support
the concept of receptor heterodimerization in this instance.
The  lack  of  support  for  Mel1a-Mel1c  receptor
heterodimerization is confirmed by the observation that serial
optical slices show a transition from only red Mel1a labeling
at the apical position to only green Mel1c labeling at the more
basal position (Figure 4). It should be emphasized that this
analysis  applies  only  to  the  mid-light  time  point,  and  as
discussed below, there is support for the concept of potential
Mel1a-Mel1c receptor heterodimerization at other times of
day (Figure 11).
Relative distribution of Mel1a and Mel1b in the corneal
surface epithelium: Double-labeling immunocytochemistry
of Mel1a and Mel1b receptors shows a distribution pattern
that is significantly different from the Mel1a-Mel1c labeling
pattern. In corneal specimens obtained at the mid-light period
(12:00  N),  the  lateral  membranes  of  the  corneal  surface
epithelium display a high level of immunoreactivity for both
receptor subtypes, as indicated by the yellow fluorescence of
the merged red and green images (Figure 5). When analyzed
in a manner identical to that described above for the Mel1a-
Mel1c  double-labeling,  a  broad  band  of  yellow
immunolabeling is observed on the lateral membranes (Figure
5B). Punctate cytoplasmic immunolabeling of the Mel1a and
Mel1b  receptors  is  not  co-localized,  indicating  that  the
receptors are located in separate cytoplasmic compartments.
Some punctate red Mel1a immunolabeling is also observed
on the lateral membranes located basal to the major yellow
fluorescence, indicating that not all the Mel1a on the lateral
membrane is in close proximity to the Mel1b receptor (Figure
5A). There is also some red Mel1a labeling interdigitating
with the broad yellow band of fluorescence, suggesting that
although much of the membrane-associated Mel1a receptor is
in very close proximity to the membranous Mel1b receptors,
a significant amount of membranous Mel1a receptor is not as
closely  associated  (Figure  5B).  In  contrast  to  the  gradual
transition from red Mel1a to green Mel1c membrane labeling
in serial optical slices (Figure 3), all serial optical slices of the
Mel1a-Mel1b  labeling,  representing  2  µm  in  thickness,
contain mostly yellow fluorescence, with some red and a very
small amount of green fluorescence interposed (Figure 6).
Taken  together,  the  receptor  double-labeling  experiments
suggest that the Mel1a and Mel1b receptors are located at
approximately the same apical/basal position on the lateral
membranes, and the Mel1c receptor is located directly basal
to that location.
Relative distribution of Mel1a and ZO-1 in the corneal
surfaceHpithelium: 'Ruble-label0el1a-ZO-1LPPXQR
cytochemistry  was  performed  in  an  attempt  to
determine the location of the melatonin receptor complex
relative to tight junctions. ZO-1 is a zonula occludens protein
associated with cytoplasmic plaques of tight junctions, and it
interacts with a wide variety of cellular proteins and plays a
central  role  in  orchestrating  tight  junction  complexes
[37-39]. The utility of ZO-1 as an excellent marker for tight
junctions  is  not  limited  to  our  interest  in  the  spatial
relationship of the melatonin receptors to tight junctions, but
is  also  valuable  for  evaluation  of  the  potential  role  of
melatonin  receptor  signaling  in  rhythmic  tight  junction
assembly. ZO-1 is primarily localized to a relatively narrow
strip of labeling on the lateral membranes (Figure 7), although
punctate  ZO-1  immunolabeling  is  often  observed  in  the
cytoplasm, as expected (Figure 8). The apical to basal width
of the band of ZO-1 immunoreactivity is significantly smaller
than  observed  for  the  band  of  Mel1a  immunoreactivity
(Figure 7), indicating that Mel1a (and by inference, Mel1b and
Mel1c)  distribution  is  more  widespread  on  the  lateral
membrane than are the tight junctions.
At  the  late  afternoon  time  point  (4:00  PM)  that  was
selected  for  this  analysis,  Mel1a  immunoreactivity  is
dispersed along the entire lateral membrane that is located
basal to the tight junctions (Figure 7). It is interesting to note
that Mel1a receptor immunoreactivity is generally lacking in
surface CE cells that have small apical profiles (Figure 7 and
Figure 8). These small profiles presumably indicate the limits
of the lateral membranes of CE cells that have just recently
emerged  at  the  surface  layer,  and  are  therefore  relatively
immature  compared  to  the  larger  surface  cells.  From  this
observation, we surmise that tight junction formation precedes
Mel1a expression in the lateral membranes of the surface
epithelium. However, we also occasionally observed some
larger mature cells expressing Mel1a receptor on the lateral
membranes,  but  not  expressing  ZO-1  immunoreactivity
(Figure  7  and  Figure  8).  ZO-1  expression  on  lateral
membranes may become diminished in mature cells, perhaps
as part of the desquamation process. It is known that tight
junction proteins pre-accumulate in the sub-superficial cells
prior to desquamation of the surface cells [12,13,40], so any
potential correlation between Mel1a expression and ZO-1
expression on the surface cells would not be indicative of a
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2398potential  role  for  melatonin  signaling  in  tight  junction
formation.
Analysis of the relative distribution of Mel1a to ZO-1
compared  to  the  localization  of  Mel1a  relative  to  Mel1c
reveals  some  interesting  features  of  melatonin  receptor
membrane localization. Surprisingly, Mel1a appears to be
more  closely  associated  with  ZO-1  than  with  Mel1c.  As
described  earlier,  the  Mel1a  (red)  labeling  appears  as  a
discrete  band  directly  apical  to  a  band  of  Mel1c  (green)
labeling, with a small amount of overlap between the red and
green fluorescence that results in a merged yellow signal
(Figure 3 and Figure 4). In contrast, when ZO-1 and Mel1a
are both expressed on CE lateral membranes, a discrete band
of green ZO-1 is not observed, and a broad red Mel1a band is
observed just basal to the thinner ZO-1-Mel1a merged yellow
signal (Figure 7 and Figure 8). Therefore, ZO-1 is in such
close proximity to Mel1a that a discrete apical ZO-1 (green)
signal is not detected, yet Mel1c is far enough away from
Mel1a to enable us to detect an apical red Mel1a signal that is
distinct from the green and yellow signals. The exception to
this  pattern  is  a  discrete  green  ZO-1  band  observed  in
immature surface CE cells in which Mel1a is not yet expressed
(Figure 7 and Figure 8). It is tempting to speculate that the
relatively close association of Mel1a with ZO-1 is a reflection
of a functional association between these proteins. There is an
emergent realization that G protein-coupled receptor (GPCR)
signaling  depends  to  some  extent  upon  association  with
organized networks of scaffolding proteins that optimize the
specificity and timing of the cellular responses. Many GPCRs
interact with the postsynaptic density protein 96 (PSD-96)/
Drosophila  Disc  large/ZO-1  homology  (PDZ)  domain-
containing  proteins  which  modulate  receptor  signaling  by
assembling the different proteins involved in the transduction
of the signal to the target proteins [41-44]. For example, the
multi-PDZ  domain  protein  (MUPP1)  interacts  with  the
COOH-terminal tail of mammalian Mel1a (MT1) to promote
Gi  coupling  and  signaling  of  the  MT1  receptor  [42].
Interestingly,  MUPP1  is  concentrated  at  tight  junctions
through interactions with junctional proteins such as claudin-1
and junctional adhesion molecule (JAM) [45], and the PDZ
domains of ZO-1 bind directly to the COOH-terminus of
claudin  [46].  These  observations  suggest  a  molecular
architectural  model  in  which  GPCRs  are  tethered  to
macromolecular  complexes  which  include  tight  junction
proteins  by  PDZ  domain  scaffolding  proteins.  The  recent
observation that the GPCR somatostatin receptor 3 interacts
with MUPP1 to control epithelial tight junction permeability
suggests that perhaps other MUPP1-associated GPCRs such
as  the  melatonin  receptors  could  potentially  contribute  to
regulation of tight junctions [47].
Diurnal  rhythm  of  Mel1a  and  Mel1c  receptor
localization: Diurnal oscillations in melatonin receptor RNA
expression, protein expression, and binding sites have been
reported in a variety of tissues and species [8,48-53]. It has
been  suggested  that  the  rhythms  in  melatonin  receptor
expression may be superimposed on the circadian rhythm in
melatonin synthesis as an additional level of regulation of
melatonin  signaling  [54].  Certainly,  the  availability  of
functional binding sites would be expected to have a profound
impact  on  the  cellular  responses  to  ligand  exposure.  In
addition  to  potential  regulation  of  melatonin  receptor
availability by alterations in receptor RNA and/or protein
synthesis,  receptor  availability  can  also  potentially  be
regulated  by  receptor  sequestration/degradation  in
intracellular  compartments  following  ligand  binding  and
receptor  activation.  Furthermore,  homodimerization,
heterodimerization,  and  association  with  macromolecular
complexes can also affect GPCR receptor activity [42,47,
55-58].
To assess the potential for daily changes in melatonin
receptor  expression  or  localization  in  Xenopus  CE,  we
performed a double-label immunocytochemical analysis of
Mel1a and Mel1c receptors in whole corneas obtained at 4-h
intervals over a 24-h period. The 8:00 AM time point (2 h after
lights on) shows a distinctive pattern in which only Mel1a,
only Mel1c, and merged Mel1a-Mel1c labeling is present in
different regions of the surface CE lateral membranes (Figure
9C). It appears that the region of membrane contact between
neighboring cells displays a uniform pattern of Mel1a and/or
Mel1c receptor expression, but when the membrane contact
changes  to  contact  with  a  different  neighboring  cell,  the
pattern of receptor labeling can change. In some membranes
that  display  the  yellow  Mel1a-Mel1c  receptor  labeling,  it
appears that co-localization may be due to expression of only
Mel1a on the cell membrane of one cell, and only Mel1c on
the cell membrane of the neighboring cell (Figure 11A,C).
However, in other areas that display the Mel1a-Mel1c merged
yellow labeling, it appears to be the result of both Mel1a and
Mel1c expression on both membranes. These observations
support the possibility that heterodimerization of Mel1a and
Mel1c exists in some, but not all, CE lateral membranes at the
8:00 AM time point. Further studies are needed to assess the
relative degrees of homodimerization and heterodimerization
of melatonin receptors at different times of day on the corneal
surface epithelium.
In contrast to the diverse Mel1a-Mel1c labeling pattern
observed at 8:00 AM, the 4:00 PM pattern of Mel1a and Mel1c
labeling  is  consistently  co-localized  (Figure  9  G-I).
Furthermore, discrete labeling of only Mel1a or only Mel1c
could not be readily discerned (Figure 11F), indicating that
the two receptors are in very close proximity to each other in
the majority of surface cells. Whether the different patterns of
relative Mel1a and Mel1c labeling observed at the 8:00 AM
and 4:00 PM time points represent daily changes in receptor
dimerization cannot be determined from this study, but it
remains a possibility that is worthy of further study. These
results do suggest that there are daily changes in melatonin
receptor  subtype  localization  on  the  surface  CE  lateral
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localization occurring late in the light period. The punctate
receptor immunolabeling that occurs in the cytoplasm during
the latter part of the light period may be the result of transport
vesicles carrying newly-synthesized receptors to the plasma
membrane. Previous reports demonstrating a diurnal rhythm
of melatonin receptor synthesis during the day support this
possibility [8,48-53].
Recent  studies  have  demonstrated  that  most  GPCRs
interact with each other to form dimers and/or oligomers, and
that this is essential for their activation [55,56,59]. GPCRs
have the ability to heterodimerize, and these heterodimers
exhibit distinct functional properties [56-58,60]. Dimerization
of GPCRs appears to be a universal phenomenon that provides
an additional mechanism for modulation of receptor function
as well as cross-talk between GPCRs [59]. Mammalian MT1
and  MT2  melatonin  receptors  (equivalent  to  Mel1a  and
Mel1b,  respectively)  can  exist  as  homodimers  and  as
heterodimers, and the relative expression and affinities of each
receptor  subtype  may  determine  the  proportion  of
homodimers  and  heterodimers  [61].  GPR50  is  an  orphan
GPCR that has been recently discovered to be the mammalian
ortholog of Mel1c [33], and to heterodimerize with MT1 and
MT2  melatonin  receptors  [58].  Heterodimerization  with
GPR50 decreases the function of the MT1 receptor because
of  an  interaction  of  the  C-terminal  tail  of  GPR50  with
regulatory  proteins  of  MT1  receptors,  whereas
heterodimerization  between  GPR50  and  MT2  does  not
modify MT2 function [58]. Our observation of a transient
close association of the Mel1a and Mel1c receptors in frog CE
provides  in  vivo  support  of  previous  reports  of  [48]
recombinant MT1-GPR50 heterodimerization in mammalian
cell  lines.  Further  studies  are  planned  to  investigate  the
potential role of melatonin receptor heterodimerization on
melatonin signaling in Xenopus CE.
At  8:00  PM  (2  h  after  lights  off),  Mel1a  labeling  is
prominent in the lateral membranes, but most of the Mel1c
labeling  is  present  in  small  punctate  cytoplasmic
compartments (perhaps endosomes) and there does not appear
to be any co-localization of the two receptor subtypes (Figure
10A-C).  One  explanation  for  this  translocation  of  Mel1c
immunolabeling from the lateral membrane to the cytoplasm
is endocytosis of the activated receptors. Interestingly, some
Mel1a receptor is translocated to large, irregular cytoplasmic
compartments four hours later at 12:00 M (Figure 10E). The
Mel1a-containing irregular cytoplasmic compartments may
represent late endosomes. These observations suggest that the
Mel1c receptor is activated and internalized earlier in the dark
period than the Mel1a receptor. Receptor internalization and
down-regulation is common in GPCRs, and some melatonin
receptors appear to be regulated by this mechanism [62-65].
Melatonin differentially regulates MT1 and MT2 (Mel1a and
Mel1b, respectively) receptors in transfected mammalian cell
lines. MT2, but not MT1, is rapidly internalized through an
arrestin-dependent mechanism after exposure to melatonin
[62,63].  Long-term  exposure  to  high  concentrations  of
melatonin  desensitizes  recombinant  MT1  receptors  in
transfected  cells  without  inducing  internalization  [64].
However, it has been recently shown that chronic exposure (5
h) of MT1-transfected cells results in receptor internalization
and β-arrestin binding [65]. The binding of β-arrestin to the
presumably  phosphorylated  MT1  in  endosomes  promotes
scaffolding of mitogen-activated protein kinase/extracellular
signal-regulated kinase 1/2 (MEK/ERK 1/2) which leads to
signaling  via  the  microtubule-associated  protein  (MAP)
kinase  pathway.  This  suggests  that  melatonin-induced
endocytosis  of  the  receptor  may  promote  intracellular
signaling when the receptors are sequestered in an endosomal
compartment. There is strong evidence that endocytosis of
some  GPCRs  is  required  for  activation  of  specific  signal
transduction  pathways  such  as  the  MAP  kinase  cascade,
suggesting  that  active  signaling  events  occur  during  the
receptor  transit  in  endosomal  compartments  [66-70].
Together, these findings support the concept that melatonin
receptor subtypes are differentially regulated, which can result
in  different  temporally-regulated  cellular  responses  to
nocturnal melatonin exposure.
Potential changes in receptor heterodimerization during
the diurnal cycle may also play an important role in regulating
the availability of the various receptor subtypes to ligand
binding. Heterodimerization can promote or inhibit the co-
internalization of both receptors after stimulation of just one
of  the  protomers  [56].  For  example,  recombinant  MT1
homodimers  are  internalized  in  response  to  melatonin
stimulation, whereas GPR50 homodimers and MT1-GPR50
heterodimers are not internalized in response to melatonin
[58]. This suggests that stimulation of the GPR50 protomer
prevents the internalization of the MT1-GPR50 heterodimer.
Based on the observations on the diurnal changes in melatonin
receptor  location,  we  suggest  this  potential  scenario:  (1)
Mel1a  and  Mel1c  are  synthesized  and  transported  via
transport vesicles to the lateral membranes during the light
period, (2) during the light period, some of the Mel1a and
Mel1c monomers form heterodimers on the lateral membrane,
although some remain as monomers or homodimers, (3) in the
dark, when melatonin levels are beginning to rise, Mel1c
receptors are stimulated and are internalized into endosomes
(which would require dissociation from Mel1a if present as
Mel1a-Mel1c heterodimers), (4) later in the dark period, as
melatonin levels continue to rise, the Mel1a receptors are
stimulated  and  some  are  internalized,  eventually  being
delivered to late endosomes, (5) as melatonin levels decline
in  the  late  dark  period  and  early  light  period,  melatonin
receptors  are  degraded  or  recycled  back  to  the  lateral
membrane, and new receptors begin to be synthesized. This
scenario is highly speculative and requires further study to
confirm or refute this possibility.
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single ligand-activated protomer that has dissociated from a
receptor heterodimer, as previously reported for somatostatin
receptor (sst) heterodimers. Somatostatin induces endocytosis
of  sst2A  and  sst3  homodimers,  but  sst2A-sst3  heterodimers
dissociate at the plasma membrane, and only sst2A, but not
sst3, undergoes ligand-induced endocytosis after exposure to
somatostatin  [71].  This  supports  our  speculation  that
melatonin binding to the Mel1a-Mel1c heterodimer induces
internalization of the Mel1c, but not the Mel1a, protomer early
in the dark period (Figure 10A,B). Furthermore, the separation
of Mel1c from Mel1a may potentially increase the sensitivity
of the Mel1a that remains on the plasma membrane [58].
Models  for  ligand-promoted  regulation  of  GPCR
heterodimerization  are  supported  by  strong  experimental
evidence [56]. Several studies suggest that ligand binding can
regulate  heterodimer  formation  by  either  promoting  or
inhibiting  dimerization  [41,72-75].  In  this  model,  GPCR
monomers and/or heterodimers on the plasma membrane may
respond to ligand binding by monomer dimerization and/or
dimer  dissociation.  Dissociated  monomers  could  then
potentially dimerize with other monomers on the membrane.
In conclusion, we have observed that Mel1a, Mel1b, and
Mel1c melatonin receptor immunoreactivity is present on the
lateral membranes and in cytoplasmic compartments of the
Xenopus laevis corneal surface epithelium. Mel1a is located
basal to the zonula occludens protein, ZO-1, and the very close
proximity  of  melatonin  receptors  to  the  tight  junctions
supports a potential role for melatonin in CE barrier function.
Mel1a and Mel1b are closely associated with each other on
the lateral membrane, but Mel1c is generally located in a basal
position to Mel1a, although in close proximity during the mid-
light period. The relative positions of the Mel1a and Mel1c
receptors  appear  to  undergo  dynamic  changes  during  the
light–dark cycle, insofar as they may co-localize late in the
day, and then perhaps dissociate following melatonin binding
at night. Cytoplasmic melatonin receptor immunoreactivity
varies  throughout  the  day,  and  may  represent  melatonin
receptor trafficking in transport vesicles and endosomes. The
expression  of  melatonin  receptors  on  the  corneal  surface
epithelium  supports  the  concept  of  a  role  for  circadian
signaling on corneal epithelial function.
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